140 related articles for article (PubMed ID: 11726565)
1. Model of counter-current transfer from vagina to urethra in postmenopausal women.
Cicinelli E; Einer-Jensen N; Galantino P; Pinto V; Barba B; Tartagni M
Hum Reprod; 2001 Dec; 16(12):2496-500. PubMed ID: 11726565
[TBL] [Abstract][Full Text] [Related]
2. Preferential vascular-based transfer from vagina to the corpus but not to the tubal part of the uterus in postmenopausal women.
Einer-Jensen N; Cicinelli E; Galantino P; Pinto V; Barba B
Hum Reprod; 2001 Jul; 16(7):1329-33. PubMed ID: 11425808
[TBL] [Abstract][Full Text] [Related]
3. Uterine first pass effect in postmenopausal women.
Einer-Jensen N; Cicinelli E; Galantino P; Pinto V; Barba B
Hum Reprod; 2002 Dec; 17(12):3060-4. PubMed ID: 12456603
[TBL] [Abstract][Full Text] [Related]
4. [Effects of menopausal factor on fine anatomy of bladder urethra and vagina in women undergoing vaginal delivery].
Chen L; Chen CL; Liu P; Feng J; Qiao WW; Tang L; Chen SZ; Chen JY; Cao XJ
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(45):3676-3680. PubMed ID: 30526778
[No Abstract] [Full Text] [Related]
5. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
Cicinelli E
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasound imaging of the lower urinary tract in post-menopausal women with urinary stress or combined type of incontinence before and after intravaginal administration of estriol].
Martan A; Masata J; Halaska M; Voigt R
Ceska Gynekol; 1999 Jan; 64(1):6-9. PubMed ID: 10377583
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
[TBL] [Abstract][Full Text] [Related]
9. Uterine prolapse: evaluation of glycosaminoglycans in postmenopausal women after estrogen therapy.
Nunes JM; Feldner PC; Castro RA; Nader HB; Sartori MG; Girão MJ
Climacteric; 2011 Feb; 14(1):121-5. PubMed ID: 20690864
[TBL] [Abstract][Full Text] [Related]
10. Effect of vaginal distention on vesicourethral function with identification of the vagino-vesicourethral reflex.
Shafik A; El-Sibai O
J Urol; 2001 Mar; 165(3):887-9. PubMed ID: 11176494
[TBL] [Abstract][Full Text] [Related]
11. Anatomic relationships of the distal third of the pelvic ureter, trigone, and urethra in unembalmed female cadavers.
Rahn DD; Bleich AT; Wai CY; Roshanravan SM; Wieslander CK; Schaffer JI; Corton MM
Am J Obstet Gynecol; 2007 Dec; 197(6):668.e1-4. PubMed ID: 18060975
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
13. Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.
Ulrich LS; Naessen T; Elia D; Goldstein JA; Eugster-Hausmann M;
Climacteric; 2010 Jun; 13(3):228-37. PubMed ID: 20423243
[TBL] [Abstract][Full Text] [Related]
14. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
[TBL] [Abstract][Full Text] [Related]
15. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
16. Vaginal oestrogen for overactive bladder in post-menopausal women.
Ostle Z
Br J Nurs; 2015 Jun 11-24; 24(11):582-5. PubMed ID: 26067792
[TBL] [Abstract][Full Text] [Related]
17. [Changes in values of urethral closure pressure and its position after Burch colposuspension--predictive value of MUCP and VLPP for successful rate of this operation].
Martan A; Masata J; Svabík K; Drahorádová P; Pavlíková M
Ceska Gynekol; 2006 May; 71(3):209-19. PubMed ID: 16768049
[TBL] [Abstract][Full Text] [Related]
18. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
19. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
[TBL] [Abstract][Full Text] [Related]
20. Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.
Maldonado PA; Montoya TI; Acevedo JF; Keller PW; Word RA
Biol Reprod; 2017 Jan; 96(1):81-92. PubMed ID: 28395337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
